文章认为,药品生产者集团和消费者集团影响政府的能力相差太远,药品消费者集团向政府表达意见的渠道太少,政府在进行药品价格规制的时候偏向药品生产者集团是药品价格虚高的根本原因。因此,解决药品价格虚高问题应从建立有利于各种利益集团合理表达意见的机制、规范药品价格听证会制度和转变政府职能等方面入手。 The article argues that the pharmaceutical producer group and the consumer group have a far different ability to influence the government. There are too few channels for the pharmaceutical consumer group to express their opinions to the government. The government tends to the drug producer group because the drug price is too high The root cause. Therefore, the solution to the problem of the high price of medicines should start with the establishment of a mechanism conducive to the reasonable expression of opinions by various interest groups, the standardization of hearing system of drug prices and the transformation of government functions.